DBCO-PEG4-VA-PBD

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

DBCO-PEG4-VA-PBD 

DBCO-PEG4-VA-PBD 是一种抗体偶联药物，由抗肿瘤抗生素 Pyrrolobenzodiazepine (PBD) 和 DBCO-PEG4-VA 连接而成。

DBCO-PEG4-VA-PBD

DBCO-PEG4-VA-PBD Chemical Structure

CAS No. : 2241644-09-5

规格 价格 是否有货
1 mg ￥16500 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

DBCO-PEG4-VA-PBD is a drug-linker conjugate for ADC by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via DBCO-PEG4-VA[1].

IC50 & Target

Traditional Cytotoxic Agents

 

体外研究
(In Vitro)

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

1430.60

Formula

C80H87N9O16
CAS 号

2241644-09-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务